Eltrombopag Olamine

Common brands: Promacta, Eltrombopag, Alvaiz, Prednisone, Prednisone Delayed Release

Top reporter: Novartis Pharmaceuticals Corporation

Corticosteroid [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]CD20-directed Cytolytic Antibody [EPC]Thrombopoietin Receptor Agonist [EPC]Proton Pump Inhibitor [EPC]
22,630
Total Reports
12,906
Serious Reports
4,839
Death Reports
30
Reported Reactions
Death Report Ratio: High (21.38%)

Patient Demographics

Male
9,235
Female
11,334

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Eltrombopag Olamine.

# Reaction Reports % of Total
1 PLATELET COUNT DECREASED 3,969
16.1%
2 DEATH 3,315
13.5%
3 DRUG INEFFECTIVE 1,943
7.9%
4 FATIGUE 1,108
4.5%
5 PLATELET COUNT INCREASED 1,107
4.5%
6 HEADACHE 968
3.9%
7 OFF LABEL USE 890
3.6%
8 NAUSEA 809
3.3%
9 DIARRHOEA 802
3.3%
10 PRODUCT USE IN UNAPPROVED INDICATION 740
3.0%
11 MALAISE 586
2.4%
12 THROMBOCYTOPENIA 582
2.4%
13 PYREXIA 547
2.2%
14 ASTHENIA 533
2.2%
15 CONTUSION 508
2.1%
16 PNEUMONIA 501
2.0%
17 HAEMORRHAGE 484
2.0%
18 PLATELET COUNT ABNORMAL 483
2.0%
19 DIZZINESS 482
2.0%
20 HAEMOGLOBIN DECREASED 447
1.8%
21 ARTHRALGIA 411
1.7%
22 PAIN 409
1.7%
23 VOMITING 408
1.7%
24 PRODUCT DOSE OMISSION ISSUE 397
1.6%
25 RASH 395
1.6%
26 EPISTAXIS 377
1.5%
27 THERAPY NON-RESPONDER 359
1.5%
28 ANAEMIA 357
1.5%
29 PAIN IN EXTREMITY 354
1.4%
30 DYSPNOEA 347
1.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.